Daphne E. Smith Marsh
Clinical Assistant Professor, College of Pharmacy - Pharmacy Practice
Director of Diversity, Equity, Engagement and Inclusion, Department of Pharmacy Practice
Contact
Address:
833 South Wood Street, Chicago, IL
Office Phone:
Email:
Related Sites:
About
Overview:
Clinical pharmacist, diabetes educator and faculty member with more than 25 years of experience, which encompasses compassionate, culturally respectful, patient-centered care.
Research Interests:
Diabetes management in indigent population, medication therapy management.
Teaching Statement:
Didactic and experiential instruction provided for professional pharmacy, medical, nursing and nutrition students and residents, with focus on diabetes therapeutic management and lifestyle modification.
Teaching and Supervision
Honors College Seminar (HON 201), 4/15/2025 – 4/15/2025
INTRODUCTORY PHARMACY PRACTICE (IPPE): INTRODUCTION TO PATIENT CARE (PHAR 414), 4/1/2025 – 4/8/2025
Chronic Kidney Disease (PMPR 381), 3/17/2025 – 3/17/2025
Pathophysiology, Drug Action & Therapeutics (PDAT )2: GI/Endocrine (PHAR 502), 2/21/2025 – 3/6/2025
PHR 5613-Pharmacotherapeutics I (PHR 5613), 11/19/2024 – Present
Introduction to Pharmacy Practice (PHAR 411), 9/25/2024 – 10/2/2024
Advanced Topics in Diabetes Management (HN 505), 6/26/2024 – 6/26/2024
Honors College Seminar (HON 201), 4/9/2024 – 4/9/2024
Chronic Kidney Disease (PMPR 381), 3/11/2024 – 3/11/2024
Selected Grants
Improving adherence to guideline-directed medical therapies in patients with type 2 diabetes and chronic kidney disease, Bayer Corp., 9/22/2025 - 9/21/2026, Obligated Amount: $20000; Anticipated Amount: $20000
Building Health Communities in Suburban Cook County/PRogram to Educate & VaccinatE uNderserved members of The public (PREVENT) Pilot, Mobile Care Chicago., 11/1/2022 - 3/24/2025, Obligated Amount: $17325; Anticipated Amount: $17325
Selected Publications
Coffee, Alexis, Marsh, Daphne Smith, Elmes‐Patel, Abigail. (2025). Additional comment on “Pharmacist‐managed diabetes care and change in A1C: A retrospective matched cohort study”. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 8, (4), 320-320. doi:10.1002/jac5.70029.
Smith Marsh, Daphne. (2025). Adverse Drug Reactions-Merck Manual Professional Version. Merck Manual. Merck & Co.,Inc.
Gerber, Ben S, Biggers, Alana, Tilton, Jessica J, Marsh, Daphne E Smith, Lane, Rachel, Mihailescu, Dan, Lee, JungAe, Sharp, Lisa K. (2023). Mobile Health Intervention in Patients With Type 2 Diabetes. JAMA Network Open, 6, (9), e2333629. doi:10.1001/jamanetworkopen.2023.33629.
Adimadhyam, Sruthi, Lee, Todd A, Calip, Gregory S, Marsh, Daphne E Smith, Layden, Brian T, Schumock, Glen T. (2019). Sodium‐glucose co‐transporter 2 inhibitors and the risk of fractures: A propensity score‐matched cohort study. Pharmacoepidemiology and Drug Safety, 28, (12), 1629-1639. doi:10.1002/pds.4900.
Adimadhyam, Sruthi, Schumock, Glen T, Calip, Gregory S, Marsh, Daphne E Smith, Layden, Brian T, Lee, Todd A. (2019). Increased risk of mycotic infections associated with sodium–glucose co‐transporter 2 inhibitors: a prescription sequence symmetry analysis. British Journal of Clinical Pharmacology, 85, (1), 160-168. doi:10.1111/bcp.13782.
Adimadhyam, Sruthi, Lee, Todd A, Calip, Gregory S, Marsh, Daphne E Smith, Layden, Brian T, Schumock, Glen T. (2018). Risk of amputations associated with SGLT2 inhibitors compared to DPP‐4 inhibitors: A propensity‐matched cohort study. Diabetes Obesity and Metabolism, 20, (12), 2792-2799. doi:10.1111/dom.13459.
Smith Marsh, DE. (2015). Managing adverse events related to SGLT2 inhibitors: What a pharmacist needs to know to optimize clinical outcomes. Pharmacy Times, 81, (4).
Smith-Marsh, D. (2013). Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.. Drugs of Today, 49, (8), 499-507. doi:10.1358/dot.2013.49.8.2002839.
Gerber, Ben S, Cano, Alejandra I, Caceres, Maria L, Smith, Daphne E, Wilken, Lori A, Michaud, Jessica B, Ruggiero, Laurie A, Sharp, Lisa K. (2010). A Pharmacist and Health Promoter Team to Improve Medication Adherence Among Latinos with Diabetes. Annals of Pharmacotherapy, 44, (1), 70-79. doi:10.1345/aph.1m389.
Professional Leadership
Practical Aspects of DEI, 9/5/2024 - 9/5/2024
ICHP DEI Committee, ICHP, 7/20/2023 - Present
ADA Wellness Village Committee, 1/6/2020 - Present
ADA Step Out Planning Committee, 7/1/2019 - 9/30/2019
Notable Honors
2025, ICHP DEIA Impact Award, Illinois Council of Health-System Pharmacists
2025, 2024-2025 Interprofessional Teacher of the Year, UIC Family Medicine Residency
2023, UIC SNPhA Service Recognition, University of Illinois at Chicago
Education
Degrees:
Doctor of Pharmacy, University of Illinois at Chicago, United States, 1997
Pre-Pharmacy Education, Jackson State University, United States, 1989
Pre-Pharmacy Education, Creighton University, United States, 1990
Postgraduate Training:
Pharmacy Practice Residency, Saint Elizabeth Hospital, United States, 1998
Licensures and Certifications
Registered Pharmacist #051-286220, State of Illinois, Date Not Set - Present
Certified Diabetes Care and Education Specialist, Association of Diabetes Care and Education Specialists, 12/1/2001 - Present
Board Certified-Advanced Diabetes Management, Association of Diabetes Care and Education Specialists, 6/20/2016 - 6/20/2026
Diversity, Equity, and Inclusion Certificate, American Society of Health-System Pharmacists, 4/30/2023 - Present